Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy

British Journal of Dermatology

Volumn 169, Issue 3, 2013, Pages 563-570

  Pivarcsi, A ^a   Meisgen, F ^a   Xu, N ^a   Sonkoly, E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; METHOTREXATE; MICRORNA; MICRORNA 106B; MICRORNA 126; MICRORNA 128A; MICRORNA 142 3P; MICRORNA 181A; MICRORNA 223; MICRORNA 26B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNITY; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE REPRESSION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; UPREGULATION; VALIDATION PROCESS;

CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MALE; MICRORNAS; MIDDLE AGED; PSORIASIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR; SEQUENCE ANALYSIS, RNA;

EID: 84883378755     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12381     Document Type: Article

References (30)

1. Alvarez-Garcia I, Miska EA,. MicroRNA functions in animal development and human disease. Development 2005; 132: 4653-62.
2. Visone R, Croce CM,. MiRNAs and cancer. Am J Pathol 2009; 174: 1131-8.
3. Bostjancic E, Zidar N, Stajer D, et al,. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 2010; 115: 163-9.
4. Sonkoly E, Pivarcsi A,. Advances in microRNAs: implications for immunity and inflammatory diseases. J Cell Mol Med 2009; 13: 24-38.
5. Sonkoly E, Wei T, Janson PC, et al,. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS ONE 2007; 2: e610.
6. Zibert JR, Lovendorf MB, Litman T, et al,. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci 2010; 58: 177-85.
7. Sonkoly E, Janson P, Majuri ML, et al,. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol 2010; 126: 581-9, e1-20.
8. Joyce CE, Zhou X, Xia J, et al,. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet 2011; 20: 4025-40.
9. Lerman G, Avivi C, Mardoukh C, et al,. MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R. PLoS ONE 2011; 6: e20916.
10. Xu N, Brodin P, Wei T, et al,. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol 2011; 131: 1521-9.
11. Meisgen F, Xu N, Wei T, et al,. MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis. Exp Dermatol 2012; 21: 312-14.
12. Cortez MA, Bueso-Ramos C, Ferdin J, et al,. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011; 8: 467-77.
13. Montecalvo A, Larregina AT, Shufesky WJ, et al,. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 2012; 119: 756-66.
14. Wang JF, Yu ML, Yu G, et al,. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 2010; 394: 184-18.
15. Weger W,. Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents. Br J Pharmacol 2010; 160: 810-20.
16. Kroh EM, Parkin RK, Mitchell PS, Tewari M,. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010; 50: 298-301.
17. Mitchell PS, Parkin RK, Kroh EM, et al,. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-18.
18. Sonkoly E, Ståhle M, Pivarcsi A,. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008; 18: 131-40.
19. Garzon R, Pichiorri F, Palumbo T, et al,. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 2006; 103: 5078-83.
20. Wang S, Aurora AB, Johnson BA, et al,. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008; 15: 261-71.
21. Castoldi M, Vujic SM, Altamura S, et al,. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest 2011; 121: 1386-96.
22. Griffiths-Jones S, Grocock RJ, van Dongen S, et al,. miRBase: micro-RNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34: D140-4.
23. Xiao C, Srinivasan L, Calado DP, et al,. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008; 9: 405-14.
24. Sonkoly E, Pivarcsi A,. microRNAs in inflammation. Int Rev Immunol 2009; 28: 535-61.
25. Leeper NJ, Raiesdana A, Kojima Y, et al,. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011; 226: 1035-43.
26. Zhao S, Wang Y, Liang Y, et al,. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2011; 63: 1376-86.
27. Mendell JT,. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008; 133: 217-22.
28. Johnnidis JB, Harris MH, Wheeler RT, et al,. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008; 451: 1125-9.
29. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, et al,. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2011; 2: 282.
30. Guerau-de-Arellano M, Smith KM, Godlewski J, et al,. Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain 2011; 134: 3578-89.